Cellular Senescence and Brain Aging: Mechanisms, Therapeutic Strategies, and Implications for Neurodegenerative Diseases
暫譯: 細胞衰老與大腦老化：機制、治療策略及對神經退行性疾病的影響

Dr. Gaurav Gupta holds a doctoral degree from Pacific University, Udaipur, Rajasthan, India. He has more than thirteen years of experience in molecular and biochemical pharmacology, including neurological disorders and respiratory diseases. Dr. Gupta is currently associated as an Adjunct Professor with the Centre for Research Impact & Outcome at Chitkara College of Pharmacy, Chitkara University, Rajpura, and the Centre for Global Health Research at Ajman University, UAE. Dr. Gupta is a highly accomplished pharmacologist with expertise in neurodegenerative diseases, cellular senescence, and molecular mechanisms of brain aging. Listed among the World's Top 2% Scientists (Stanford University, 2020-2024), Dr. Gupta has authored over 700 peer-reviewed publications, with a cumulative impact factor exceeding 5000, an H-index of 64, and more than 19,800 citations. His research focuses on the roles of cellular senescence, oxidative stress, and neuroinflammation in Alzheimer's, Parkinson's, and other neurodegenerative diseases, as well as respiratory diseases. His editorial contributions include Springer volumes on inflammatory lung diseases, epigenetics, and molecular pharmacology.

高拉夫·古普塔博士擁有印度拉賈斯坦邦烏代浦爾的太平洋大學博士學位。他在分子和生化藥理學方面擁有超過十三年的經驗，涵蓋神經系統疾病和呼吸系統疾病。古普塔博士目前擔任奇特卡大學藥學院研究影響與成果中心的兼任教授，以及阿吉曼大學全球健康研究中心的研究員。古普塔博士是一位成就卓越的藥理學家，專長於神經退行性疾病、細胞衰老和大腦老化的分子機制。他被列為全球前2%的科學家（史丹佛大學，2020-2024），發表了超過700篇經過同行評審的出版物，累計影響因子超過5000，H指數為64，引用次數超過19,800次。他的研究重點在於細胞衰老、氧化壓力和神經炎症在阿茲海默症、帕金森病及其他神經退行性疾病以及呼吸系統疾病中的角色。他的編輯貢獻包括斯普林格出版社關於炎症性肺病、表觀遺傳學和分子藥理學的專著。